Ontario fund invests $1 million in Interface Biologics

The Ontario Government’s Investment Accelerator Fund-Life Sciences (IAF-LS), which helps accelerate the growth of life sciences companies in Ontario, has invested $1 million in closely held Interface Biologics. “We are very pleased that the IAF-LS has chosen Interface as one of the limited number of life sciences companies they are funding,” Interface CEO Tom Reeves [...]

Medical devices to grow 4% to 6% annually

The global market for medical devices will hit the $312 billion (U.S.) in 2011, driven by device innovations and an aging population, with annual growth forecast at 4% to 6%, according to a new study by Kalorama Information. While industry growth has slowed in recent years due to the recession, “there are many drivers on [...]

IMRIS in $18-million bought deal

IMRIS (TSX:IM) of Winnipeg opened the financing window, signing an $18-million bought deal to sell 3.21 million shares at a price of $5.60 each with a syndicate of underwriters led by RBC Capital Markets Inc. The syndicate has a 30-day option to purchase an additional 482,250 shares of IMRIS at the same price, which would [...]